Cerus Corp (CERS)

6.65
0.08 1.22
NASDAQ : Health Care
Prev Close 6.57
Open 6.83
Day Low/High 6.60 / 6.83
52 Wk Low/High 4.27 / 6.89
Volume 1.03M
Avg Volume 1.08M
Exchange NASDAQ
Shares Outstanding 101.71M
Market Cap 661.12M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

CERS September 16th Options Begin Trading

CERS September 16th Options Begin Trading

Investors in Cerus Corp. saw new options become available today, for the September 16th expiration.

Cerus Provides An Update On Adoption By Blood Centers Of America Members For The INTERCEPT Blood System For Platelets And Plasma

Cerus Provides An Update On Adoption By Blood Centers Of America Members For The INTERCEPT Blood System For Platelets And Plasma

Cerus Corporation (NASDAQ:CERS) announced today that blood center members representing 54% of the aggregate volume of platelets produced by Blood Centers of America (BCA) have executed participation agreements for adoption...

Cerus And CEI Announce Donation Of INTERCEPT Blood System Kits To HEMORIO For Emergency Preparedness Ahead Of The Summer Olympic Games In Rio De Janeiro

Cerus And CEI Announce Donation Of INTERCEPT Blood System Kits To HEMORIO For Emergency Preparedness Ahead Of The Summer Olympic Games In Rio De Janeiro

Cerus Corporation (NASDAQ:CERS) and its distribution partner CEI Group (Brazil) today announced a donation of INTERCEPT Blood System pathogen reduction kits for platelets and plasma to HEMORIO, a public hospital responsible...

Cerus To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference On July 13, 2016

Cerus To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference On July 13, 2016

Cerus Corporation (NASDAQ:CERS) announced today that Kevin Green, Cerus' vice president, finance and chief financial officer, is scheduled to present a corporate update at the Cantor Fitzgerald Healthcare Conference at 1:30...

Cerus Corporation, The Transfusion Service Of The Swiss Red Cross, And The University Hospital Of Basel Receive A Grant Of 2 Million Swiss Francs From The Swiss Red Cross Humanitarian Foundation For Whole Blood Pathogen Inactivation For Africa

Cerus Corporation, The Transfusion Service Of The Swiss Red Cross, And The University Hospital Of Basel Receive A Grant Of 2 Million Swiss Francs From The Swiss Red Cross Humanitarian Foundation For Whole Blood Pathogen Inactivation For Africa

Cerus Corporation (NASDAQ:CERS), announced today that the Swiss Red Cross Humanitarian Foundation has awarded a grant of 2 million Swiss Francs to Cerus, the University Hospital of Basel, and the Swiss Transfusion SRC to...

Interesting CERS Put And Call Options For February 2017

Interesting CERS Put And Call Options For February 2017

Investors in Cerus Corp. saw new options begin trading this week, for the February 2017 expiration.

Cerus Announces Agreement With BARDA For Potential Funding Of Up To Approximately $180 Million To Advance Its INTERCEPT Red Blood Cell Program

Cerus Announces Agreement With BARDA For Potential Funding Of Up To Approximately $180 Million To Advance Its INTERCEPT Red Blood Cell Program

Cerus Corporation (NASDAQ: CERS), a biomedical products company focused on improving blood transfusion safety, today announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA), part of...

July 15th Options Now Available For Cerus (CERS)

July 15th Options Now Available For Cerus (CERS)

Investors in Cerus Corp. saw new options become available today, for the July 15th expiration.

Health Canada Approves INTERCEPT Blood System For Plasma

Health Canada Approves INTERCEPT Blood System For Plasma

Cerus Corporation (NASDAQ:CERS) today announced that Health Canada has approved the INTERCEPT Blood System for plasma.

Cerus (CERS): Today's Weak On High Volume Stock

Cerus (CERS): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Cerus (CERS) as a weak on high relative volume candidate

Trade-Ideas: Cerus (CERS) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Cerus (CERS) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Cerus (CERS) as a weak on high relative volume candidate

Cerus is Now Oversold (CERS)

Cerus is Now Oversold (CERS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cerus Corporation Reports First Quarter 2016 Results

Cerus Corporation Reports First Quarter 2016 Results

Cerus Corporation (NASDAQ:CERS) today announced financial results for the first quarter ended March 31, 2016.

Cerus Announces That The Walter Reed National Military Medical Center Has Entered Into Routine Use Of The INTERCEPT Blood System

Cerus Announces That The Walter Reed National Military Medical Center Has Entered Into Routine Use Of The INTERCEPT Blood System

Cerus Corporation (NASDAQ:CERS), a biomedical products company focused in the field of blood transfusion safety, announced today that the Walter Reed National Military Medical Center (Walter Reed), a component of the Armed...

Cerus To Present At The Deutsche Bank 41st Annual Health Care Conference On May 5, 2016

Cerus To Present At The Deutsche Bank 41st Annual Health Care Conference On May 5, 2016

Cerus Corporation (NASDAQ:CERS) announced today that William "Obi" Greenman, president and chief executive officer, is scheduled to present a corporate update at the Deutsche Bank 41 st Annual Health Care Conference at 1:30...

Cerus To Release First Quarter 2016 Results On May 3, 2016

Cerus To Release First Quarter 2016 Results On May 3, 2016

Cerus Corporation (NASDAQ:CERS) announced today that its first quarter results will be released on Tuesday, May 3, 2016, after the close of the stock market.

CERS June 17th Options Begin Trading

CERS June 17th Options Begin Trading

Investors in Cerus Corp. saw new options begin trading today, for the June 17th expiration.

Interesting CERS Put And Call Options For November 18th

Interesting CERS Put And Call Options For November 18th

Investors in Cerus Corp. saw new options become available this week, for the November 18th expiration.

Insider Trading Alert - AMRK, CERS And CWT Traded By Insiders

Insider Trading Alert - AMRK, CERS And CWT Traded By Insiders

Stocks with insider trader activity include AMRK, CERS and CWT

Cerus Receives FDA Approval For Use Of The INTERCEPT Blood System For Platelets Suspended In 100% Plasma

Cerus Receives FDA Approval For Use Of The INTERCEPT Blood System For Platelets Suspended In 100% Plasma

Cerus Corporation (NASDAQ: CERS), a biomedical products company focused on improving blood transfusion safety, today announced U.

Cerus (CERS) Is Strong On High Volume Today

Cerus (CERS) Is Strong On High Volume Today

Trade-Ideas LLC identified Cerus (CERS) as a strong on high relative volume candidate

Cerus (CERS) Stock Jumping on Q4 Results

Cerus (CERS) Stock Jumping on Q4 Results

Cerus (CERS) stock is rising in afternoon trading on Wednesday after the company posted its 2015 fourth quarter results after yesterday’s closing bell.

Blood Centers Of America Selects Cerus As Its Supply Partner For Pathogen Reduction Technology

Blood Centers Of America Selects Cerus As Its Supply Partner For Pathogen Reduction Technology

Cerus Corporation (NASDAQ: CERS) and Blood Centers of America (BCA) announced today that they have entered into an agreement with Cerus as a BCA preferred supplier.

How Will Cerus (CERS) Stock React to Q4 Results?

How Will Cerus (CERS) Stock React to Q4 Results?

Cerus (CERS) reported its 2015 fourth quarter results after Tuesday’s closing bell.

Cerus Corporation Reports Fourth Quarter And Year End 2015 Results

Cerus Corporation Reports Fourth Quarter And Year End 2015 Results

Cerus Corporation (NASDAQ:CERS) today announced financial results for the fourth quarter and year ended December 31, 2015.

Cerus Enters Into Agreement With Banco De Sangre De Servicios Mutuos For The Use Of INTERCEPT Platelets And Plasma In Puerto Rico To Sustain Blood Supply During Zika Epidemic

Cerus Enters Into Agreement With Banco De Sangre De Servicios Mutuos For The Use Of INTERCEPT Platelets And Plasma In Puerto Rico To Sustain Blood Supply During Zika Epidemic

Cerus Corporation (NASDAQ: CERS), a biomedical products company focused on improving blood transfusion safety, today announced that Banco de Sangre de Servicios Mutuos in Puerto Rico has signed a purchase agreement for...

Cerus To Present At The Cowen And Company 36th Annual Health Care Conference On March 9, 2016

Cerus To Present At The Cowen And Company 36th Annual Health Care Conference On March 9, 2016

Cerus Corporation (NASDAQ:CERS) announced today that William "Obi" Greenman, president and chief executive officer, is scheduled to present a corporate update at the Cowen and Company 36th Annual Health Care Conference at...